1-3 of 3
Marius Horger, MD
Close
Sort by
Journal Articles

Whole-Body Reduced-Dose CT As Primary Staging and during Follow-up in First-Line Treatment of Transplant-Eligible Multiple Myeloma Patients: Results of the German GMMG-MM5 Trial

Katja Weisel, MD, Marius Horger, MD, Hartmut Goldschmidt, MD, Lothar Kanz, MD, Stefan Delorme, MD, Jens Hillengass, MD
Journal: Blood
Blood (2014) 124 (21): 3356.
https://doi.org/10.1182/blood.V124.21.3356.3356
Published: 2014
Journal Articles

Immunotherapy With RNA Vaccination Coding For TAA In Renal Cell Carcinoma: Update On Immunological Responses and Correlation With Survival

Susanne M Rittig, MD, Maik Häntschel, MD, Katrin J Weimer, MD, Annkristin Heine, MD, Martin R Müller, MD, PhD, Wolfram Brugger, MD, Marius Horger, MD, Olga Maksimovic, MD, Arnulf Stenzl, MD, Ingmar Hoerr, Hans-Georg Rammensee, Tobias A.W. Holderried, MD, Lothar Kanz, MD, Steve Pascolo, Peter Brossart, MD
Journal: Blood
Blood (2013) 122 (21): 1040.
https://doi.org/10.1182/blood.V122.21.1040.1040
Published: 2013
Journal Articles

Clinical and Radiographic Course of Bone Disease in Relapsed Multiple Myeloma in the Era of Novel Agents: Occurrence, Definition and Impact of Resclerosis Documented by Whole-Body Low-Dose Multidetector Computed Tomography

Katharina Oehrlein, MD, Marius Horger, MD, Anja Schmidt, Manola Zago, PhD, Maximilian Schulze, MD, Lothar Kanz, MD, Katja C Weisel, MD
Journal: Blood
Blood (2012) 120 (21): 3963.
https://doi.org/10.1182/blood.V120.21.3963.3963
Published: 2012